Inhibition of CSRP2 Promotes Leukemia Cell Proliferation and Correlates with Relapse in Adults with Acute Myeloid Leukemia

BACKGROUND: Relapse is a major obstacle in the treatment of acute myeloid leukemia (AML). Refinement of risk stratification may aid the identification of patients who are likely to relapse. Abnormal cysteine and glycine-rich protein 2 (CSRP2) has been implicated in various cancers, but its function rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shujuan, Zhang, Yu, Liu, Yajun, Zheng, Ruyue, Wu, Zhenzhen, Fan, Yi, Li, Mengya, Li, Menglin, Li, Tao, Li, Yafei, Jiang, Zhongxing, Wang, Chong, Liu, Yanfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733086/
https://www.ncbi.nlm.nih.gov/pubmed/33324073
http://dx.doi.org/10.2147/OTT.S281802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733086/
https://www.ncbi.nlm.nih.gov/pubmed/33324073
http://dx.doi.org/10.2147/OTT.S281802

Ejemplares similares